Model N has acquired Kalderos, a technology company providing a gross-to-net intelligence platform with capabilities for visibility into 340B drug discount programs. The acquisition expands Model N's revenue management platform for life sciences manufacturers and extends its 340B offerings. Kalderos' Truzo solution delivers real-time data visibility across multiple drug discount programs, enabling compliance monitoring, claim validation, and dispute resolution. Model N's 2026 State of Revenue Report found that only 1% of life sciences revenue leaders have real-time visibility into 340B discounts, Medicaid and Medicare rebates, and utilization rebates. The combined solution will connect contracting, claims validation, and dispute and payment processes, helping customers act on potential discount issues with clear, supporting data.
Acquires Kalderos to expand 340B and gross-to-net revenue management platform, enhancing product capabilities.
Acquired by Model N, likely providing liquidity and valuation event for Kalderos shareholders.